{"disease":{"id":"hepatic-metastasis","name":"hepatic metastasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07153783","title":"Interventional AI-Human Collaboration for Liver Tumor Diagnosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":10333,"lead_sponsor_name":"Shengjing Hospital","has_results":false},{"nct_id":"NCT06023966","title":"A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT05027711","title":"Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University Hospital Heidelberg","has_results":false},{"nct_id":"NCT01493713","title":"Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Grupo Espanol Multidisciplinario del Cancer Digestivo","has_results":false},{"nct_id":"NCT06085976","title":"Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT07504471","title":"Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06538623","title":"Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT07284836","title":"Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT07476651","title":"Scout Dose of Resin Microspheres","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04202978","title":"Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":23,"lead_sponsor_name":"Zhongshan Hospital Xiamen University","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}